CYP2D6 and atrial fibrillation: Probing the relationship between diltiazem efficacy and the genetic polymorphism of CYP2D6 in the patients suffering from AF with RVR, this study suggests that wt/wt (*1/*1), assumed to be the normal allele, is the most significant group in which drug efficacy is achieved.